Clinical Trial Update: LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma [NA]

View source ↗

Summary

Clinical trial update for LIBERTY, a study using liquid biopsy to diagnose and monitor CNS involvement in high-risk B-cell non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Non-hodgkin Lymphoma, B Cell | NA | Status: ACTIVE_NOT_RECRUITING